Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending July 5, 2020 Colonoscopy over age 75 should be ‘carefully considered’, Pubovaginal sling during urethral diverticulectomy reduces stress incontinence, Sepsis readmissions risk linked to residence in a poor neighborhoods, Zoledronic acid fails to impact abdominal aortic calcification, Triple inhaler combo quells COPD exacerbations, More must reads Must reads for theWeek ending June 28, 2020 Combo drug improves survival in older patients with high-risk/secondary AML, Venetoclax plus LDAC tops LDAC alone in AML, Endoscopic full-thickness resection of colorectal lesions appears safe and effective, Suicide thoughts, attempts in adolescence correlate with mental health symptoms, DECT has mixed performance in differentiating gout vs. CPPD, More must readsMust reads for theWeek ending June 14, 2020 High-frequency spinal cord stimulation eases painful diabetic neuropathy, Half of young adults with diabetes have diastolic dysfunction, EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetes, Many COVID patients shed virus in feces, even without GI symptoms, Electrosurgical choices lead to similar results, More must readsMust reads for theWeek ending June 14, 2020 High-frequency spinal cord stimulation eases painful diabetic neuropathy, Half of young adults with diabetes have diastolic dysfunction, EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetes, Many COVID patients shed virus in feces, even without GI symptoms, Electrosurgical choices lead to similar results, More must readsMust reads for theWeek ending May 31, 2020 ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer, Trastuzumab deruxtecan proves active in HER2-mutated NSCLC, Short-course radiotherapy and chemo may reduce treatment failures in high-risk rectal cancer, TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancer, First-line nivolumab plus platinum/etoposide effective in extensive-stage SCLC, More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 next › last »
